QQ客服 官方微博 反馈留言

	Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China
	Zhou, Lei; Liu, Weibin; Li, Wei; Li, Haifeng; Zhang, Xu; Shang, Huifang; Zhang, Xu; Bu, Bitao; Deng, Hui; Fang, Qi
刊名	THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
	2017
卷号	10期号:9页码:315-325
关键词	immunology myasthenia gravis tacrolimus
DOI	10.1177/1756285617721092
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4590198
专题	山东大学
作者单位	1.Fudan Univ, Huashan Hosp, Dept Neurol, 12 Wulumuqi Middle Rd, Shanghai 200040, Peoples R China. 2.[Liu, Weibi
推荐引用方式 GB/T 7714	Zhou, Lei,Liu, Weibin,Li, Wei,et al. Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China[J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS,2017,10(9):315-325.
APA	Zhou, Lei.,Liu, Weibin.,Li, Wei.,Li, Haifeng.,Zhang, Xu.,...&Z 更多.(2017).Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China.THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS,10(9),315-325.
MLA	Zhou, Lei,et al."Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China".THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS 10.9(2017):315-325.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。